Zobrazeno 1 - 10
of 754
pro vyhledávání: '"Lunt, M"'
In order to understand underlying processes governing environmental and physical processes, and predict future outcomes, a complex computer model is frequently required to simulate these dynamics. However there is inevitably uncertainty related to th
Externí odkaz:
http://arxiv.org/abs/1702.03696
Publikováno v:
Journal of Frailty & Aging; Oct2023, Vol. 12 Issue 4, p298-304, 7p
Autor:
Felson, D.T., Parkes, M.J., Marjanovic, E.J., Callaghan, M., Gait, A., Cootes, T., Lunt, M., Oldham, J., Hutchinson, C.E.
Publikováno v:
In Osteoarthritis and Cartilage December 2012 20(12):1514-1518
Publikováno v:
Quality of Life Research, 2008 Feb 01. 17(1), 159-167.
Externí odkaz:
https://www.jstor.org/stable/40302245
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Yiu, ZZN, Mason, KJ, Barker, JNWN, Hampton, PJ, McElhone, K, Smith, CH, Warren, RB, Griffiths, CEM, Lunt, M, Burden, AD, Study Group, BADBIR
Publikováno v:
The British Journal of Dermatology
Yiu, Z Z N, Mason, K J, Barker, J N W N, Hampton, P J, McElhone, K, Smith, C H, Warren, R B, Griffiths, C E M, Lunt, M & Burden, A D 2019, ' A standardization approach to compare treatment safety and effectiveness outcomes between clinical trials and real-world populations in psoriasis ', British Journal of Dermatology . https://doi.org/10.1111/bjd.17849
Yiu, Z Z N, Mason, K J, Barker, J N W N, Hampton, P J, McElhone, K, Smith, C H, Warren, R B, Griffiths, C E M, Lunt, M & Burden, A D 2019, ' A standardization approach to compare treatment safety and effectiveness outcomes between clinical trials and real-world populations in psoriasis ', British Journal of Dermatology . https://doi.org/10.1111/bjd.17849
Summary Background Patients recruited in randomized controlled trials (RCTs) for biologic therapies in psoriasis are not fully representative of the real‐world psoriasis population. Objectives Firstly, to investigate whether patient characteristics
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::038c4f12ba259f0b976cbdefb61e60c1
http://europepmc.org/articles/PMC6916305
http://europepmc.org/articles/PMC6916305
Autor:
Yiu, Z.Z.N., Sorbe, C., Lunt, M., Rustenbach, S.J., Kühl, L., Augustin, M., Mason, K.J., Ashcroft, D.M., Griffiths, C.E.M., Warren, R.B.
Publikováno v:
The British Journal of Dermatology
Summary Background Patients with psoriasis are often concerned about the risk of serious infection associated with systemic psoriasis treatments. Objectives To develop and externally validate a prediction model for serious infection in patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7f50d68ffbb03867b62b095862c2064a
http://europepmc.org/articles/PMC6850093
http://europepmc.org/articles/PMC6850093
Autor:
Stedman, M, Whyte, Mb, Lunt, M, Albanese, M, Livingston, M, Gadsby, R, Hackett, G, Anderson, Sg, Heald, Ah
Publikováno v:
Stedman, M, Whyte, M, Lunt, M, Albanese, M, Livingston, M, Gadsby, R, Hackett, G, Anderson, S & Heald, A 2020, ' The treatment rate of erectile dysfunction (ED) in younger men with Type 2 Diabetes is up to 4 times higher than the equivalent non-diabetes population ', International Journal of Clinical Practice . https://doi.org/10.1111/ijcp.13538, https://doi.org/10.1111/ijcp.13538
Introduction Erectile Dysfunction (ED) is common in older age and in diabetes (DM). Phosphodiesterase type 5‐inhibitors (PDE5‐is) are the first‐line for ED. We investigated how type of diabetes and age of males affects the PDE5‐i use in the p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3818::7afddabf1c26599aff36ec063a3d95e0
https://research.manchester.ac.uk/en/publications/e97f595e-1391-4793-83bb-fb223d39014a
https://research.manchester.ac.uk/en/publications/e97f595e-1391-4793-83bb-fb223d39014a